- Home
- ASA vs ORGO Comparison
ASA vs ORGO Comparison
Compare ASA & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASA
- ORGO
- Stock Information
- Founded
- ASA 1958
- ORGO 1985
- Country
- ASA United States
- ORGO United States
- Employees
- ASA N/A
- ORGO N/A
- Industry
- ASA Precious Metals
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- ASA Industrials
- ORGO Health Care
- Exchange
- ASA Nasdaq
- ORGO Nasdaq
- Market Cap
- ASA 697.1M
- ORGO 620.3M
- IPO Year
- ASA N/A
- ORGO N/A
- Fundamental
- Price
- ASA $52.95
- ORGO $4.06
- Analyst Decision
- ASA
- ORGO Buy
- Analyst Count
- ASA 0
- ORGO 3
- Target Price
- ASA N/A
- ORGO $7.33
- AVG Volume (30 Days)
- ASA 154.4K
- ORGO 777.6K
- Earning Date
- ASA 10-28-2025
- ORGO 11-06-2025
- Dividend Yield
- ASA 0.12%
- ORGO N/A
- EPS Growth
- ASA 335.96
- ORGO N/A
- EPS
- ASA 19.90
- ORGO N/A
- Revenue
- ASA $3,982,215.00
- ORGO $429,531,000.00
- Revenue This Year
- ASA N/A
- ORGO $2.51
- Revenue Next Year
- ASA N/A
- ORGO $25.45
- P/E Ratio
- ASA $2.62
- ORGO N/A
- Revenue Growth
- ASA 99.75
- ORGO N/A
- 52 Week Low
- ASA $19.37
- ORGO $2.61
- 52 Week High
- ASA $53.76
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- ASA 81.83
- ORGO 40.18
- Support Level
- ASA $46.18
- ORGO $3.84
- Resistance Level
- ASA $49.14
- ORGO $4.40
- Average True Range (ATR)
- ASA 1.81
- ORGO 0.18
- MACD
- ASA 0.40
- ORGO -0.01
- Stochastic Oscillator
- ASA 94.02
- ORGO 39.29
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.